These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23600375)

  • 1. A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes.
    Haji Ali Afzali H; Gray J; Beilby J; Holton C; Banham D; Karnon J
    Diabet Med; 2013 Jul; 30(7):855-63. PubMed ID: 23600375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary care.
    Karnon J; Ali Afzali HH; Gray J; Holton C; Banham D; Beilby J
    Obesity (Silver Spring); 2013 Mar; 21(3):472-9. PubMed ID: 23592655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in Australia.
    Haji Ali Afzali H; Gray J; Beilby J; Holton C; Karnon J
    Appl Health Econ Health Policy; 2013 Dec; 11(6):661-70. PubMed ID: 24243516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.
    Dijkstra RF; Niessen LW; Braspenning JC; Adang E; Grol RT
    Diabet Med; 2006 Feb; 23(2):164-70. PubMed ID: 16433714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.
    Laxy M; Wilson ECF; Boothby CE; Griffin SJ
    Value Health; 2017 Dec; 20(10):1288-1298. PubMed ID: 29241888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice nurse involvement in primary care depression management: an observational cost-effectiveness analysis.
    Gray J; Haji Ali Afzali H; Beilby J; Holton C; Banham D; Karnon J
    BMC Fam Pract; 2014 Jan; 15():10. PubMed ID: 24422622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of care for the management of complex Type 2 diabetes managed in the community by primary care physicians with specialist support: an open controlled trial.
    Russell AW; Baxter KA; Askew DA; Tsai J; Ware RS; Jackson CL
    Diabet Med; 2013 Sep; 30(9):1112-21. PubMed ID: 23758279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.
    Bebb C; Kendrick D; Stewart J; Coupland C; Madeley R; Brown K; Burden R; Sturrock N
    Diabet Med; 2005 Oct; 22(10):1364-71. PubMed ID: 16176198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States.
    Aagren M; Luo W
    J Med Econ; 2011; 14(1):108-14. PubMed ID: 21241161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
    Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
    Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada.
    Tunis SL; Sauriol L; Minshall ME
    Appl Health Econ Health Policy; 2010; 8(4):267-80. PubMed ID: 20578781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial.
    Xin Y; Davies A; McCombie L; Briggs A; Messow CM; Grieve E; Leslie WS; Taylor R; Lean MEJ
    Diabet Med; 2019 Aug; 36(8):1003-1012. PubMed ID: 31026353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States.
    Minshall ME; Roze S; Palmer AJ; Valentine WJ; Foos V; Ray J; Graham C
    Clin Ther; 2005 Jun; 27(6):940-50. PubMed ID: 16117994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme.
    Varroud-Vial M; Simon D; Attali J; Durand-Zaleski I; Bera L; Attali C; Letondeur C; Strauss K; Petit C; Charpentier G
    Diabet Med; 2004 Jun; 21(6):592-8. PubMed ID: 15154945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland.
    Segal L; Nguyen H; Schmidt B; Wenitong M; McDermott RA
    Med J Aust; 2016 Mar; 204(5):1961e-9. PubMed ID: 26985851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.